A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 276 participants.

Also called NCT07227532

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 276 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07227532
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07227532. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Acronym
AdmIREPAS
Intervention (Device)
Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07227532
Content hash
e3207f64ec16feb7bda4f189e8bdf814d8b95f8aa579f6e918fdb8032574e87c